Swiss Q3 GDP contracts 0.5% amid tariff pressures – Commerzbank
The final Swiss growth figures for the third quarter, published on Friday, were ultimately as poor as the initial estimate of growth adjusted for sport events, standing at -0.5% quarter-on-quarter. This was slightly below expectations, with the Bloomberg consensus predicting a contraction of 0.4%.

The final Swiss growth figures for the third quarter, published on Friday, were ultimately as poor as the initial estimate of growth adjusted for sport events, standing at -0.5% quarter-on-quarter. This was slightly below expectations, with the Bloomberg consensus predicting a contraction of 0.4%. This was the first negative growth since the first half of 2023, Commerzbank's FX analyst Michael Pfister notes.

First negative growth since early 2023 for Switzerland

"The third quarter was significantly impacted by US tariffs, which increased to 39% at the start of August, while most major trading partners were granted lower tariffs. Net exports have essentially caused growth to slump; in the first quarter, they had the opposite effect due to front-loading effects. It is therefore advisable to consider the past three quarters in aggregate rather than focusing on individual quarters. Now that a preliminary deal has been reached with the US and tariffs are being reduced, we are likely to see better figures in the coming months."

"A more problematic issue for the Swiss economy is its dependence on the pharmaceutical industry. Until around 2014, gross value added in the pharmaceutical sector grew in line with other industries. However, since then, this relationship has become significantly decoupled. In other words, much of Switzerland's relatively strong growth in recent years has been due to the pharmaceutical industry, with other sectors contributing less."

"This dependence could become problematic in the long term, particularly as the US administration is seeking to shift production for the US market from other countries to the US, and several large Swiss pharmaceutical companies have announced substantial investments in the US that would not be made in Switzerland. However, it will probably take several years to see the effects of such production shifts. In the short term, the contraction in the third quarter due to US tariffs, and the expected recovery in growth, are likely to play a greater role. It is therefore not surprising that the Swiss Franc (CHF) gained slightly against the euro on Friday."

超过一百万用户依赖 FXStreet 获取实时市场数据、图表工具、专家洞见和外汇新闻。其全面的经济日历和教育网络研讨会帮助交易者保持信息领先、做出审慎决策。FXStreet 拥有约 60 人的团队,分布在巴塞罗那总部及全球各地区。
阅读更多

实时报价

名称 / 代码
图表
涨跌幅 / 价格
GBPUSD
1日涨跌幅
+0%
0
EURUSD
1日涨跌幅
+0%
0
USDJPY
1日涨跌幅
+0%
0

关于 FOREX 的一切

探索更多工具
交易学院
浏览涵盖交易策略、市场洞察和金融基础知识的广泛教育文章,一站式学习。
了解更多
课程
探索结构化的交易课程,旨在支持您在交易旅程的每个阶段的成长。
了解更多
网络研讨会
参加现场和点播网络研讨会,从行业专家那里获得实时市场洞察和交易策略。
了解更多